Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter ... - CNNMoney.com (press release) Print
CNNMoney.com (press release)"The Phase 2a results demonstrate the ability of RDEA594 to normalize renal excretion of uric acid in patients that have gout due to their inability to

... read more